前列腺癌放疗患者SpaceOAR水凝胶分布及早期并发症
回顾性分析160例接受水凝胶间隔物置入的前列腺癌患者,于MRI评估水凝胶分布及直肠壁浸润,并记录早期并发症。结果显示73.1%分布对称,平均直肠前列腺间距10.2±3.7 mm,直肠壁浸润率低,仅2例需急诊处理。
要点
- MRI评估水凝胶分布:73.1%患者呈对称分布,平均直肠前列腺间距10.2±3.7 mm。
- 直肠壁浸润少见:7例(4.3%)轻微浸润,1例(0.6%)中度浸润。
- 早期并发症发生率低:1.3%需急诊处理(尿潴留和疼痛各1例)。
核心结论
- 经会阴水凝胶置入可在放疗前将前列腺与直肠分开,多数病例分布对称,直肠壁注射和早期并发症发生率低。
研究设计与样本
- 回顾性研究,纳入160例接受水凝胶间隔物置入的患者,于MRI评估水凝胶分布,并记录早期并发症。
关键影像表现/征象
- 117例(73.1%)患者水凝胶间隔物呈对称分布。
- 平均直肠前列腺前后间距为10.2±3.7 mm(范围0-27 mm)。
- 7例(4.3%)患者有轻微直肠壁浸润,1例(0.6%)有中度浸润。
- 1例(0.6%)患者发生前列腺内注射。
临床应用与阅片要点
- MRI可用于评估水凝胶间隔物的分布及有无直肠壁注射等异位放置。
- 早期并发症包括尿潴留和疼痛,需急诊处理的比例为1.3%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Hydrogel spacers aim to separate the rectum from the prostate during radiation therapy for patients with prostate cancer to decrease the radiation dose and thus toxicity to the rectum. The aim of this study was to evaluate the distribution of the hydrogel spacer between the rectum and the prostate, to assess for hydrogel rectal wall infiltration and to assess for immediate complications.
METHODS: Retrospective study of 160 patients who had undergone hydrogel spacer placement. Distribution of the hydrogel was assessed on MRI. MRI images were reviewed for rectal wall injection or other malplacement of gel. Early post-procedure complications were recorded.
RESULTS: 117 (73.1%) patients had a symmetrical distribution of the hydrogel spacer. The mean anteroposterior rectoprostatic separation was 10.2 ± 3.7 mm (range 0-27 mm). Seven (4.3%) patient had minimal rectal wall infiltration and one (0.6%) patient had moderate infiltration. One (0.6%) patient had an intraprostatic injection of hydrogel. Two (1.3%) patients required treatment in the emergency department: one for urinary retention and one for pain.
CONCLUSIONS: Transperineal hydrogel placement separates the prostate from the rectum with a symmetrical distribution in the majority of cases prior to radiation therapy with a low rate of rectal wall injection and immediate complications.
ADVANCES IN KNOWLEDGE: SpaceOAR hydrogel can be safely injected into radiation naive patients with low- or intermediate-risk organ-confined prostate cancer. The spacer separates the prostate from the rectum with a symmetrical distribution in the majority of cases prior to radiation therapy.
引用
- Yates AH, Power JW, Dempsey PJ, et al. SpaceOAR hydrogel distribution and early complications in patients undergoing radiation therapy for prostate cancer. Br J Radiol. 2023. PMID: 37660394. doi:10.1259/bjr.20220947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。